Archer is now part of IDT, bringing the future of precision oncology to cancer care. The transaction was completed December 2022. Learn more here. 

Webinar: Advanced comprehensive genomic panels for myeloid neoplasms

Implementation and practice of Anchored Multiplex PCR (AMP™) technology at Genpath Oncology
February 21, 2023, 1 pm EST

The global fight against cancer requires advanced molecular detection products that are accurate, actionable, easy-to-use and available worldwide.

Our products and services

Investigational Liquid-biopsy Based Cancer Recurrence Detection

Clinical Research Services

Co-development Services
We aim to address barriers to bringing precision oncology to patients, anywhere
We are global
We provide expansive
access
menu home-icon-silhouette remove-button twitter linkedin-1 facebook-circular-logo right